Get the latest Science News and Discoveries
Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer
The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells
None
Or read this on Scientific American
